Li Z - Search Results

1

Exploring the tetrahydroisoquinoline thiohydantoin scaffold blockade the androgen receptor as potent anti-prostate cancer agents.

Xu X, Ge R, Li L, Wang J, Lu X, Xue S, Chen X, Li Z, Bian J. Xu X, et al. Among authors: li z, li l. Eur J Med Chem. 2018 Jan 1;143:1325-1344. doi: 10.1016/j.ejmech.2017.10.031. Epub 2017 Oct 14. Eur J Med Chem. 2018. PMID: 29117897

2

Design and synthesis of 7-alkoxy-4-heteroarylamino-3-quinolinecarbonitriles as dual inhibitors of c-Src kinase and nitric oxide synthase.

Cao X, You QD, Li ZY, Guo QL, Shang J, Yan M, Chern JW, Chen ML. Cao X, et al. Bioorg Med Chem. 2008 Jun 1;16(11):5890-8. doi: 10.1016/j.bmc.2008.04.065. Epub 2008 Apr 29. Bioorg Med Chem. 2008. PMID: 18485715

3

Recent progress of SRC family kinase inhibitors as anticancer agents.

Cao X, You QD, Li ZY, Wang XJ, Lu XY, Liu XR, Xu D, Liu B. Cao X, et al. Mini Rev Med Chem. 2008 Sep;8(10):1053-63. doi: 10.2174/138955708785740634. Mini Rev Med Chem. 2008. PMID: 18782057 Review.

4

Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitors.

Li Z, Zhai F, Zhao L, Guo Q, You Q. Li Z, et al. Bioorg Med Chem Lett. 2009 Jan 15;19(2):406-9. doi: 10.1016/j.bmcl.2008.11.061. Epub 2008 Nov 21. Bioorg Med Chem Lett. 2009. PMID: 19058964

5

Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.

You QD, Li ZY, Huang CH, Yang Q, Wang XJ, Guo QL, Chen XG, He XG, Li TK, Chern JW. You QD, et al. J Med Chem. 2009 Sep 24;52(18):5649-61. doi: 10.1021/jm900469e. J Med Chem. 2009. PMID: 19715319

6

Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.

Zhang X, Wang R, Zhao L, Lu N, Wang J, You Q, Li Z, Guo Q. Zhang X, et al. Among authors: li z. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1276-81. doi: 10.1016/j.bmcl.2011.10.019. Epub 2011 Oct 24. Bioorg Med Chem Lett. 2012. PMID: 22079759

7

Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives.

Fu W, Wang J, Yu L, Zhao L, Lu N, You Q, Guo Q, Li Z. Fu W, et al. Among authors: li z. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1118-21. doi: 10.1016/j.bmcl.2011.11.117. Epub 2011 Dec 6. Bioorg Med Chem Lett. 2012. PMID: 22196122

8

Synthesis and biological evaluation of baicalein derivatives as potent antitumor agents.

Luo R, Wang J, Zhao L, Lu N, You Q, Guo Q, Li Z. Luo R, et al. Among authors: li z. Bioorg Med Chem Lett. 2014 Mar 1;24(5):1334-8. doi: 10.1016/j.bmcl.2014.01.053. Epub 2014 Jan 27. Bioorg Med Chem Lett. 2014. PMID: 24507925

9

Recent androgen receptor antagonists in prostate cancer.

Lu X, Dun K, Wang Y, Yang Y, You Q, Li Z. Lu X, et al. Among authors: li z. Mini Rev Med Chem. 2014;14(8):655-63. doi: 10.2174/1389557514666140622203207. Mini Rev Med Chem. 2014. PMID: 24958215 Review.

10

Research progress of indoleamine 2,3-dioxygenase inhibitors.

Jiang T, Sun Y, Yin Z, Feng S, Sun L, Li Z. Jiang T, et al. Among authors: li z. Future Med Chem. 2015;7(2):185-201. doi: 10.4155/fmc.14.151. Future Med Chem. 2015. PMID: 25686005 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113,477 results

Search Page

Filters